| Value | ₹151.2 Cr |
|---|
BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,364.50
- Market cap
- ₹15,911 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 93.8×Sector 45.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Other Announcement
AstraZeneca Pharma India filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold 75% of total equity.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
Other legal & regulatory announcements
All →Lyka Labs Legal & Regulatory
Lyka Labs was fined ₹1.62 Lakhe by NSE for delayed FY 2025-26 Annual Report filing. The company has rectified the lapse and will pay within 15 days.
- Value
- ₹0.02 Cr
Jindal Poly Films Legal & Regulatory
Jindal Poly Films disclosed an NCLT petition under Sections 241-242 against Brookfield-linked investor Project Holdings Fourteen over oppression and mismanagement of subsidiary JPL Films. Related arbitration and Delhi High Court proceedings are pending, with financial impact not quantifiable.
Patel Chem Specialities Legal & Regulatory
BSE imposed a ₹0.01 Crore fine on Patel Chem Specialties for perceived LODR Reg 34 non-compliance. The company disputes the penalty, citing an inadvertent filing-year selection error.
- Value
- ₹0.01 Cr
Jyoti Legal & Regulatory
Jyoti Ltd received a rectification order from the Income Tax Department for AY 2020-21. The order levies an income tax demand of Rs.6.82 Crore including interest.
- Value
- ₹6.82 Cr
ICICI Bank Legal & Regulatory
ICICI Bank received an Order in Appeal confirming a GST penalty of Rs.6.95 lakh. The bank will appeal the order within prescribed timelines.
- Value
- ₹0.07 Cr
DIC India Legal & Regulatory
DIC India's GST demand for FY 2021-22 was reduced on appeal to Rs.1.29 lakh from Rs.4.68 lakh. The company is evaluating the order.
- Value
- ₹0.01 Cr